A global pharmaceutical company is about to give Cuyahoga County's manufacturing scene a serious lift, with roughly 300 new jobs headed to the Bedford Laboratories site in Bedford. The hiring push will center on the Northfield Road facility, positioning the long-running plant for a fresh wave of production activity.
Bedford Plant Set for Major Hiring Wave
According to Crain's Cleveland Business, the company, identified as Hikma Pharmaceuticals, plans to expand operations at the Bedford Laboratories campus at 300 Northfield Rd and create about 300 jobs in Cuyahoga County. Crain's reports that the announcement came from the company and local leaders on Monday, with the Bedford site sitting squarely at the center of the hiring plans.
Part of Hikma's Bigger U.S. Bet
Hikma has already been leaning hard into U.S. production. In June 2025, the company pledged $1 billion to expand domestic manufacturing and R&D capacity, according to PR Newswire. That announcement notes that Hikma operates sites in Ohio, including facilities in Columbus and Cleveland, and frames the investment as part of a broader push to increase U.S. production of essential generic medicines.
What It Means for the Region
Local economic-development leaders welcomed the news, saying the influx of positions will bolster manufacturing opportunities in Bedford and across Cuyahoga County. The planned addition of roughly 300 roles stands out as a concrete example of the wider trend of pharmaceutical firms scaling up U.S. production capacity, with Bedford landing a notable slice of that growth.
What Happens Next
Company and local spokespeople said more details, including a firm hiring timeline and where to apply, will be released as plans are finalized. This story will be updated as officials publish application information and a recruiting timetable for the Bedford site.
